In September 2015, the Patent Trial and Appeal Board denied four more petitions by Stryker Corporation (SYK) for inter partes review of U.S. Patent Nos. 7,471,310, 7,821,530, 7,844,657, and 8,439,821, owned by Karl Storz Endoscopy-America, Inc. (IPR2015-00672, Paper 9; IPR2015-00674, Paper 9; IPR2015-00764, Paper 13; IPR2015-00679, Paper 9.) The PTAB also denied in part Stryker’s two petitions for IPR of KSEA’s U.S. Patent No. 8,069,420. (IPR2015-00677, Paper 15; IPR2015-00678, Paper 12.) The KARL STORZ patents are directed to video imaging systems (‘310 and ‘530 patents), systems for controlling medical devices in an operating room (‘657 and ‘821 patents), and systems for controlling the communication of medical imaging data (‘420 patent). KARL STORZ commercializes the technology and Stryker is one of its competitors.
By Alan Harrison The USPTO issued a Guidance Update, effective July 17, 2024, to address the evolving landscape of patent eligibility, particularly in relation to artificial intelligence (AI). It seeks to clarify and update the [Read More…]
By Meghan E. McDermott Today, branding is everything – it is arguably one of the most important assets a company can have. So, whether you are starting a new brand or re-branding, any type of [Read More…]
Copyright law includes an interesting clause at 17 U.S.C. § 203: (3) Termination of the grant may be effected at any time during a period of five years beginning at the end of thirty-five years [Read More…]